The US’ stance on Covid-19 vaccines under HHS chief Robert F. Kennedy Jr. is coming into focus with a new approval framework, ...

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...

TIGIT drug collaboration. Company will wind down operations and sell assets, including EOS-984 and EOS-215 programs.

Veru's enobosarm shows safety when combined with Wegovy, Advanz-Alvotech expand biosimilar deal, Keros gets Glass Lewis support, and GeNeuro receives debt moratorium.

Compass awaits Phase 3 COMP360 trial results for treatment-resistant depression amid renewed optimism for psychedelics.

Post-Hoc Live to discuss John Carroll's Endpoints 100 survey on biopharma industry sentiment, featuring Kyle LaHucik, ...

Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

One of the nation’s premier cancer institutions is looking at a hefty second batch of capital to support future drugs in the ...

Hetero Labs could launch its generic sleep disorder drug as early as 2040 under a settlement deal with Axsome Therapeutics.

The CDC will no longer recommend routine Covid-19 vaccines for healthy kids and pregnant women after HHS Secretary Robert F.

Boundless Bio halts BBI-355 monotherapy & combinations due to toxicity, shifts to BBI-355/BBI-825 combo. Cuts 33% of staff to ...

Sernova chairman Ross Haghighat resigns after DOJ indictment on 16 insider trading counts related to Novartis' $3.2B Chinook ...